Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 19850302)

1.

Oxidative stress and neopterin abnormalities in schizophrenia: a longitudinal study.

Chittiprol S, Venkatasubramanian G, Neelakantachar N, Babu SV, Reddy NA, Shetty KT, Gangadhar BN.

J Psychiatr Res. 2010 Apr;44(5):310-3. doi: 10.1016/j.jpsychires.2009.09.002. Epub 2009 Oct 21.

PMID:
19850302
2.

Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.

Sarandol A, Kirli S, Akkaya C, Altin A, Demirci M, Sarandol E.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1164-9. Epub 2007 Mar 21.

PMID:
17459548
3.

Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.

Venkatasubramanian G, Chittiprol S, Neelakantachar N, Shetty T, Gangadhar BN.

Schizophr Res. 2010 Jun;119(1-3):131-7. doi: 10.1016/j.schres.2010.01.033. Epub 2010 Mar 11.

PMID:
20226630
4.

Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.

Zhang XY, Zhou DF, Qi LY, Chen S, Cao LY, Chen da C, Xiu MH, Wang F, Wu GY, Lu L, Kosten TA, Kosten TR.

Psychopharmacology (Berl). 2009 May;204(1):177-84. doi: 10.1007/s00213-008-1447-6. Epub 2009 Jan 13.

PMID:
19139851
5.

Longitudinal study of beta2-microglobulin abnormalities in schizophrenia.

Chittiprol S, Venkatasubramanian G, Neelakantachar N, Reddy NA, Shetty KT, Gangadhar BN.

Int Immunopharmacol. 2009 Sep;9(10):1215-7. doi: 10.1016/j.intimp.2009.07.002. Epub 2009 Jul 19.

PMID:
19596084
6.

A defect in the antioxidant defense system in schizophrenia.

Virit O, Altindag A, Yumru M, Dalkilic A, Savas HA, Selek S, Erel O, Herken H.

Neuropsychobiology. 2009;60(2):87-93. doi: 10.1159/000239684. Epub 2009 Sep 21.

PMID:
19776652
7.

Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia.

Dakhale GN, Khanzode SD, Khanzode SS, Saoji A.

Psychopharmacology (Berl). 2005 Nov;182(4):494-8. Epub 2005 Oct 19.

PMID:
16133138
8.

Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics.

Dakhale G, Khanzode S, Khanzode S, Saoji A, Khobragade L, Turankar A.

Neuropsychobiology. 2004;49(4):205-9.

PMID:
15154399
9.

The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.

Zhang XY, Chen da C, Xiu MH, Wang F, Qi LY, Sun HQ, Chen S, He SC, Wu GY, Haile CN, Kosten TA, Lu L, Kosten TR.

Schizophr Res. 2009 Sep;113(2-3):151-7. doi: 10.1016/j.schres.2009.05.016. Epub 2009 Jun 21.

PMID:
19540723
10.

Increased serum neopterin levels in acutely ill and recovered schizophrenic patients.

Korte S, Arolt V, Peters M, Weitzsch C, Rothermundt M, Kirchner H.

Schizophr Res. 1998 Jun 22;32(1):63-7.

PMID:
9690336
11.

Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.

Qi LY, Xiu MH, Chen da C, Wang F, Kosten TA, Kosten TR, Zhang XY.

Neurosci Lett. 2009 Sep 22;462(2):113-7. doi: 10.1016/j.neulet.2009.06.019. Epub 2009 Jun 17.

PMID:
19539717
12.

High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: a longitudinal 31P MRS study of basal ganglia.

Jayakumar PN, Gangadhar BN, Venkatasubramanian G, Desai S, Velayudhan L, Subbakrishna D, Keshavan MS.

Psychiatry Res. 2010 Mar 30;181(3):237-40. doi: 10.1016/j.pscychresns.2009.10.010. Epub 2010 Feb 11.

PMID:
20153149
13.

The changes of aggregability of blood platelets in schizophrenia.

Dietrich-Muszalska A, Olas B.

World J Biol Psychiatry. 2009;10(2):171-6.

PMID:
19514099
14.

Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients.

Mackeprang T, Kristiansen KT, Glenthoj BY.

Biol Psychiatry. 2002 Nov 1;52(9):863-73.

PMID:
12399139
15.

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance.

Akyol O, Herken H, Uz E, Fadillioğlu E, Unal S, Söğüt S, Ozyurt H, Savaş HA.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jun;26(5):995-1005.

PMID:
12369276
16.

Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.

Pirildar S, Gönül AS, Taneli F, Akdeniz F.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jul;28(4):709-13.

PMID:
15276697
17.

[Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].

Baskak SC, Ozsan H, Baskak B, Devrimci Ozgüven H, Kinikli G.

Turk Psikiyatri Derg. 2008 Spring;19(1):5-12. Turkish.

18.

Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.

Popovic V, Doknic M, Maric N, Pekic S, Damjanovic A, Miljic D, Popovic S, Miljic N, Djurovic M, Jasovic-Gasic M, Dieguez C, Casanueva FF.

Neuroendocrinology. 2007;85(4):249-56. Epub 2007 Jun 15.

PMID:
17570902
19.

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients.

Ascher-Svanum H, Peng X, Faries D, Montgomery W, Haddad PM.

BMC Psychiatry. 2009 Jul 29;9:46. doi: 10.1186/1471-244X-9-46.

20.

Oxidative stress markers after laparoscopic and open cholecystectomy.

Stipancic I, Zarkovic N, Servis D, Sabolović S, Tatzber F, Busic Z.

J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):347-52.

PMID:
16108734
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk